ViaDerma, Inc. (VDRM)

0,0067 -0,0011 (-14,06%) Börsenschluss: 03:23PM EDT

ViaDerma, Inc.

4640 Admiralty Way
Suite 500
Marina del Rey, CA 90292
United States
310 496 5744
https://viadermalicensing.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Qing Hua Lin	Chief Financial Officer and Director	4,46k	N/A	1981
Mr. Baotang Zhao	Chief Sales Officer	28,77k	N/A	1978
Mr. Zhang Xie	Corporate Secretary and Director	9,18k	N/A	1979
Dr. Christopher A Otiko	Founder, Chief Executive Officer and President	N/A	N/A	N/A
Dr. Andrew Berman M.D., MPH	Medical Director and Member of Advisory Board	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2011 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.

Corporate Governance

ViaDerma, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.